Investor Stock List
Ranked #7,608 of 8,699 institutional investors

Kalehua Capital Management LLC

Dallas, TX

$123M
US stock portfolio at live prices · today −$236K (−0.19%)
Live prices, last trade 12:41 PM ET
Value at quarter end (Q3 2026)
$132M
Change from Q2 2026
−$181.1M (−57.77%)
Positions
18 · 6 new, 8 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$10.7M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
BOXX 14.3%MANE 14.2%KRSA 13.4%XFOR 9.08%SRZN 6.73%
StockSharesValue, live% of portfoliovs Q2 2026
BOXX Alpha Architect 1-3 Month Box ETF148,471$17.7M14.3%Reduced −34%
MANE Veradermics Inc145,695$17.5M14.2%Reduced −50%
KRSA Korsana Biosciences, Inc.442,653$16.6M13.4%New
XFOR X4 Pharmaceuticals, Inc.3,722,840$11.2M9.08%Reduced −50%
SRZN Surrozen, Inc.286,092$8.3M6.73%Reduced −63%
SEPN Septerna, Inc.194,544$7.6M6.15%Reduced −50%
ACRS Aclaris Therapeutics, Inc.1,832,365$6.3M5.13%Reduced −50%
KRRO Korro Bio, Inc.473,595$5.9M4.76%Added +17%
IKT Inhibikase Therapeutics, Inc.3,821,890$5.2M4.21%Reduced −50%
OBX Obsidian Therapeutics, Inc.416,649$5.0M4.02%New
BETRF BetterLife Pharma Inc.27,710,000$3.8M3.10%New
ATTO Attovia Therapeutics, Inc.200,000$3.0M2.46%New
GOSS Gossamer Bio, Inc.139,366$1.6M1.27%Reduced −50%
LONA LeonaBio, Inc.393,701$911K0.74%Reduced −50%
RNA Atrium Therapeutics, Inc.112,652$799K0.65%New
MIST Milestone Pharmaceuticals Inc.1,651,258$619K0.50%Reduced −35%
TIL Instil Bio, Inc.99,600$533K0.43%Reduced −50%
KZIA Kazia Therapeutics Limited56,013$264K0.21%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
CMPS COMPASS Pathways plc1,639,384$13.3M
MLTX MoonLake Immunotherapeutics351,468$3.9M
NVCT Nuvectis Pharma, Inc.200,000$3.8M
TYRA Tyra Biosciences, Inc.148,930$3.0M
ANL Adlai Nortye Group Ltd.226,415$2.0M
SION Sionna Therapeutics, Inc.394,144$1.1M
TCRX TScan Therapeutics, Inc.909,752$137K
KPTIQ Karyopharm Therapeutics Inc.1,371,288$45K